Glycerin Suppositories Use in Very Low Birth Weight Infants

Shalinkumar Patel1, Narendra Dereddy1, Ajay J Talati1

  • 1Division of Neonatology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.

Insights

Glycerin suppositories (GS) use in very low birth weight (VLBW) infants was associated with longer hospital stays and delayed enteral feeding. Further research is needed to confirm safety and efficacy in this vulnerable population.

Area of Science:

  • Neonatalogy
  • Pediatric Gastroenterology

Background:

  • Very low birth weight (VLBW) infants often experience gastrointestinal issues.
  • Glycerin suppositories (GS) are commonly used in neonatal intensive care units (NICUs).

Purpose of the Study:

  • To investigate the characteristics of VLBW infants receiving GS.
  • To evaluate the association between GS use and clinical outcomes in VLBW infants.

Main Methods:

  • Retrospective study of 1,073 VLBW infants (500-1,499g) admitted to a level III NICU.
  • Comparison of outcomes between infants who received GS and those who did not.
  • Multivariate analyses controlling for gestational age and small for gestational age status.

Main Results:

  • Nearly half of VLBW infants (49.1%) received GS.
  • No significant difference in necrotizing enterocolitis incidence between groups.
  • GS group showed significantly longer time to full enteral feeds and hospital stay.

Conclusions:

  • Frequent GS use in VLBW infants is associated with prolonged enteral feeding and hospitalization.
  • GS may serve as a marker for gastrointestinal dysmotility, indicating potential unfavorable outcomes.
  • Prospective studies are warranted to assess the safety and efficacy of GS in VLBW infants.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.1K
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
693
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
808
Lower GI Series: Barium Enema01:23

Lower GI Series: Barium Enema

A Barium Enema, or a lower GI series, is a specialized radiographic examination designed to visualize the lower gastrointestinal tract, specifically the colon and rectum. This procedure is instrumental in diagnosing various conditions such as colorectal cancer, polyps, diverticulosis, and inflammatory bowel disease.
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
2.2K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
879